Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amy Hassan"'
Autor:
Jason A. Mouabbi, Akshara Singareeka Raghavendra, Roland L. Bassett, Amy Hassan, Debu Tripathy, Rachel M. Layman
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The addition of targeted therapies (TT) to endocrine therapy (ET) has improved the outcomes of patients with HR-positive, HER2-negative metastatic breast cancer (mBC). However, it is unknown whether patients with invasive lobular carcinoma (
Externí odkaz:
https://doaj.org/article/982f3e9cb56b48ee9ecd4add8542b9a0
Autor:
Jason Mouabbi, Akshara Singareeka Raghavendra, Matthias Christgen, Amy Hassan, Gabriel N. Hortobagyi, Debu Tripathy, Rachel M. Layman
Publikováno v:
Cancer Research. 83:P3-05
Background: Lobular carcinoma in situ (LCIS) is known to be a risk factor for the development of invasive lobular carcinoma (ILC). Recent genetic analysis indicates that LCIS is a facultative precursor of ILC. It was reported that ~50% of ILC co-occu
Autor:
Jason A. Mouabbi, Amy Hassan, Bora Lim, Gabriel N. Hortobagyi, Debasish Tripathy, Rachel M. Layman
Publikováno v:
Breast Cancer Research and Treatment. 193:253-264
Autor:
Jason A. Mouabbi, Akshara Singareeka Raghavendra, Roland L. Bassett, Amy Hassan, Debasish Tripathy, Rachel M. Layman
Publikováno v:
JAMA Network Open. 6:e2313017
ImportanceApproximately 45% to 60% of hormone receptor (HR)–positive metastatic breast cancer (mBC) shows a low-level expression of ERBB2. Low ERBB2 expression is defined as ERBB2 immunohistochemical expression of 1+ or 2+ with a negative ERBB2 amp
Autor:
Jason Mouabbi, Akshara Singareeka Raghavendra, Roland Bassett, Amy Hassan, Debu Tripathy, Rachel M. Layman
Publikováno v:
Cancer Research. 83:P5-02
Background: About 55% of hormone receptor (HR)-positive metastatic breast cancer (mBC) show a low-level expression of human epidermal growth factor receptor 2 (HER2-low). HER2-low is defined as HER2 immunohistochemistry (IHC) expression of 1+ or 2+ w
Autor:
Jason A, Mouabbi, Amy, Hassan, Bora, Lim, Gabriel N, Hortobagyi, Debasish, Tripathy, Rachel M, Layman
Publikováno v:
Breast cancer research and treatment. 193(2)
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer after invasive ductal carcinoma (IDC), accounting for 10-15% of all breast cancer cases. Although most ILCs are of the luminal A intrinsic subtype, with fa